A detailed history of Groupama Asset Managment transactions in Repligen Corp stock. As of the latest transaction made, Groupama Asset Managment holds 3,252 shares of RGEN stock, worth $390,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,252
Previous 2,494 30.39%
Holding current value
$390,500
Previous $449 Million 33.34%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $129,451 - $157,982
758 Added 30.39%
3,252 $598 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $284,739 - $462,262
2,494 New
2,494 $449 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.66B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.